Arent Fox partner Rich Berman will speak on the topic of “Intellectual Property and Generic Competition” at the Third Annual FDA Regulatory and Compliance Symposium. His presentation will take place on August 23.

The FDA Regulatory and Compliance Symposium will help drugmakers prepare for the full impact of the many changes flowing from the FDA and Congress, while clarifying many of the uncertainties. The Symposium will also provide solutions to the challenges and risks faced throughout the product life cycle - from the drug pipeline to manufacturing to patient delivery.